Promoting Safety of Medicines for Children
Geneva, Switzerland: World Health Organization, 2007: 61 p. [Online] Accessed: http://www.who.int/medicines/publications/essentialmedicines/Promotion_safe_med_childrens.pdf [2009 January 21]
"Pharmacovigilance and medicine safety issues in children are relevant to everyone who has an interest in and cares about the health of children. The purpose of this guideline is I) to present a case for the importance of the improving safety monitoring of medicines for children, II) to describe possible ways of achieving it and III) to provide an outline for national pharmacovigilance programmes to make them more sensitive and open to adverse reactions to medicines in children." [from report back cover]
Showing items related by title, author, creator and subject.
Unknown author (2007-10-06)
Recommendations of the Gene Therapy Advisory Committee / Committee on Safety of Medicines working party on retroviruses May 2005 Gene Therapy Advisory Committee [GTAC]; Committee on Safety of Medicines [CSM] (2005-10)
Parke, Dennis V. (1995-07)